HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hermann Einsele Selected Research

blue dextran

1/2018Comparative Analysis of Inflammatory Cytokine Release and Alveolar Epithelial Barrier Invasion in a Transwell® Bilayer Model of Mucormycosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hermann Einsele Research Topics

Disease

140Multiple Myeloma
12/2022 - 05/2003
88Neoplasms (Cancer)
12/2022 - 04/2005
72Infections
06/2022 - 02/2000
30Graft vs Host Disease (Graft-Versus-Host Disease)
10/2022 - 05/2003
28Aspergillosis
02/2022 - 04/2002
25Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 12/2002
23Leukemia
04/2020 - 10/2006
18Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2009
16Neutropenia
01/2021 - 02/2002
14Mycoses (Diseases, Fungus)
01/2017 - 05/2002
13Invasive Fungal Infections
06/2021 - 10/2003
12Lymphoma (Lymphomas)
10/2022 - 12/2005
12Communicable Diseases (Infectious Diseases)
02/2020 - 10/2003
11Disease Progression
01/2022 - 04/2005
11Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 04/2008
9Cytomegalovirus Infections (Inclusion Disease)
01/2019 - 02/2002
8Bronchiolitis Obliterans Syndrome
10/2022 - 04/2011
8Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020 - 12/2005
7Neoplasm Metastasis (Metastasis)
12/2022 - 01/2012
7Residual Neoplasm
01/2022 - 06/2011
7Virus Diseases (Viral Diseases)
01/2020 - 11/2002
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2022 - 12/2005
6Bites and Stings (Sting)
01/2022 - 04/2016
6Thrombocytopenia (Thrombopenia)
01/2021 - 02/2002
6Cytokine Release Syndrome
01/2020 - 12/2011
5Inflammation (Inflammations)
06/2019 - 01/2010
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 04/2008
5Necrosis
02/2017 - 10/2002
5Fever (Fevers)
12/2015 - 10/2003
5Rheumatoid Arthritis
04/2014 - 08/2007
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022 - 03/2016
4Invasive Pulmonary Aspergillosis
02/2022 - 10/2003
4Primary Myelofibrosis (Myelosclerosis)
01/2022 - 12/2009
4Anemia
10/2021 - 01/2012
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 01/2013
4Pneumonia (Pneumonitis)
01/2021 - 12/2006
4Lymphopenia (Lymphocytopenia)
01/2021 - 03/2004
4Melanoma (Melanoma, Malignant)
01/2020 - 02/2012
4Sepsis (Septicemia)
01/2020 - 10/2003
4Peripheral Nervous System Diseases (PNS Diseases)
03/2017 - 12/2005
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 02/2008
4Hypoxia (Hypoxemia)
08/2016 - 07/2007
3Renal Insufficiency (Renal Failure)
06/2022 - 06/2011
3COVID-19
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

24Bortezomib (Velcade)FDA Link
01/2022 - 12/2005
24Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 08/2007
19Chimeric Antigen ReceptorsIBA
06/2022 - 01/2019
19Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2002
19AntigensIBA
06/2021 - 05/2002
18Lenalidomide (CC 5013)FDA Link
01/2022 - 02/2008
16CytokinesIBA
06/2021 - 10/2002
15Monoclonal AntibodiesIBA
01/2022 - 12/2006
14Antiviral Agents (Antivirals)IBA
01/2020 - 02/2000
13Proteasome InhibitorsIBA
01/2022 - 12/2005
12Biomarkers (Surrogate Marker)IBA
03/2021 - 05/2013
10Chemokine ReceptorsIBA
11/2022 - 04/2015
10Pharmaceutical PreparationsIBA
01/2022 - 04/2008
10Biological ProductsIBA
07/2019 - 01/2010
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 12/2006
9Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 05/2010
8blinatumomabIBA
01/2020 - 08/2008
7Immunomodulating AgentsIBA
01/2022 - 01/2015
7fludarabineIBA
01/2022 - 12/2006
7AntibodiesIBA
01/2021 - 05/2004
7DNA (Deoxyribonucleic Acid)IBA
12/2019 - 02/2002
7PanobinostatIBA
10/2017 - 10/2014
6daratumumabIBA
01/2022 - 01/2020
6Thalidomide (Thalomid)FDA Link
01/2021 - 08/2009
6Dasatinib (BMS 354825)FDA Link
01/2019 - 04/2008
6Anti-Bacterial Agents (Antibiotics)IBA
02/2011 - 11/2002
5Immunoglobulins (Immunoglobulin)IBA
12/2022 - 08/2011
5pomalidomideIBA
01/2022 - 01/2015
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 04/2009
5carfilzomibIBA
01/2021 - 07/2016
5MicroRNAs (MicroRNA)IBA
01/2021 - 01/2014
5Phosphotransferases (Kinase)IBA
01/2020 - 10/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2018 - 10/2002
5Rituximab (Mabthera)FDA Link
03/2016 - 12/2006
5Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2015 - 01/2007
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2015 - 10/2003
468Ga-pentixaforIBA
11/2022 - 08/2020
4Busulfan (Busulfex)FDA Link
01/2022 - 12/2009
4Melphalan (Alkeran)FDA LinkGeneric
11/2021 - 10/2004
4B-Cell Maturation AntigenIBA
01/2021 - 01/2020
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2020 - 01/2017
4galactomannanIBA
08/2020 - 10/2003
4ixazomibIBA
01/2020 - 01/2017
4elotuzumabIBA
01/2020 - 08/2015
4Fluconazole (Zonal)FDA LinkGeneric
04/2019 - 10/2003
4Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2015 - 05/2003
3Surface Antigens (Surface Antigen)IBA
01/2022 - 01/2020

Therapy/Procedure

128Therapeutics
06/2022 - 02/2000
67Stem Cell Transplantation
02/2022 - 02/2002
38Hematopoietic Stem Cell Transplantation
10/2022 - 10/2003
34Drug Therapy (Chemotherapy)
01/2022 - 06/2002
33Immunotherapy
01/2022 - 10/2003
31Transplantation
01/2022 - 08/2000
17Cell Transplantation
01/2022 - 11/2005
10Homologous Transplantation
01/2022 - 06/2003
4Salvage Therapy
04/2022 - 12/2006